An interventional study of Autogenic Relaxation and Surah Ar-Rahman Murottal Therapy and listening to dangdut music in Chronic Kidney Disease Stage V, End-Stage Renal Disease and Hemodialysis, sponsored by Universitas Muhammadiyah Surakarta. Not yet recruiting at 1 site in Indonesia. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-02-17.
Sponsored by Universitas Muhammadiyah Surakarta · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This quasi-experimental study aims to evaluate the effect of combined autogenic relaxation and Surah Ar-Rahman murottal therapy on anxiety, sleep quality, and hemodynamic parameters in hemodialysis patients. A pretest-posttest control group design will be used involving 76 participants undergoing routine hemodialysis. Participants will be assigned to an intervention group receiving structured autogenic relaxation followed by murottal therapy and a control group receiving standard care with music listening. Anxiety, sleep quality, and hemodynamic parameters will be measured at baseline and after a 6-week intervention period. The findings are expected to support the use of non-pharmacological and spiritual-based interventions in improving psychological and physiological outcomes in hemodialysis patients.
This study applies a quasi-experimental pretest-posttest control group design. The intervention group receives structured autogenic relaxation followed by Surah Ar-Rahman murottal therapy for 10-15 minutes per session, twice weekly for six weeks. The control group receives standard hemodialysis care with music listening. Anxiety, sleep quality, and hemodynamic parameters are assessed before and after the intervention.
2,115 studies on the registry are indexed under Kidney Failure, Chronic; 277 are open to participants now.
This study's planned enrollment of 76 is above the median of 57 across 1,573 interventional studies indexed under Kidney Failure, Chronic.
Browse Kidney Failure, Chronic studies →Universitas Muhammadiyah Surakarta is the lead sponsor of 11 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in this group receive structured autogenic relaxation followed by Surah Ar-Rahman murottal therapy during hemodialysis sessions. The intervention is administered twice weekly for six weeks, with each session lasting 10-15 minutes. The procedure is conducted by trained nurses under researcher supervision in a quiet and comfortable environment.
Behavioral: Autogenic Relaxation and Surah Ar-Rahman Murottal Therapy
listening to dangdut music for 10 to 15 minutes within 6 weeks
Other: listening to dangdut music
A structured non-pharmacological intervention consisting of autogenic relaxation techniques including breathing regulation, muscle relaxation, and self-suggestion, followed by listening to Surah Ar-Rahman murottal recitation using earphones. Each session lasts 10-15 minutes and is conducted twice weekly for six weeks during routine hemodialysis.
listening to dangdut music for 10 to 15 minutes within 6 weeks
Anxiety
Change in anxiety level measured using the Zung Self-Rating Anxiety Scale (ZSAS; range 20-80), where higher scores indicate greater anxiety, from baseline to after completion of the 6-week intervention.
Time frame: Baseline and after completion of the 6-week intervention
Sleep Quality
Change in sleep quality measured using the Pittsburgh Sleep Quality Index (PSQI; range 0-21), where higher scores indicate poorer sleep quality, from baseline to after completion of the 6-week intervention.
Time frame: Baseline and after completion of the 6-week intervention.
Blood Presure
Change in systolic blood pressure (mmHg), measured using a calibrated digital sphygmomanometer, from baseline to after completion of the 6-week intervention.
Time frame: Baseline and after completion of the 6-week intervention
Heart Rate
Change in heart rate (beats per minute, bpm), measured using a digital bedside patient monitor, from baseline to after completion of the 6-week intervention.
Time frame: Baseline and after completion of the 6-week intervention
Plan to share: No
Start is estimated for Mar 2026; primary completion for May 2026, 2 months later.
Of 349 non-industry interventional studies with no phase under Kidney Failure, Chronic, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 47. This study's planned 2 months is below that.
Counting every sponsor, half of 427 studies reached it within 22 months; a quarter within 8 and three quarters within 45.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universitas Muhammadiyah Surakarta